{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:56:27Z","timestamp":1790207787580,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.exphem.2013.03.008","type":"journal-article","created":{"date-parts":[[2013,3,30]],"date-time":"2013-03-30T13:38:34Z","timestamp":1364650714000},"page":"615-626","source":"Crossref","is-referenced-by-count":12,"title":["Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"41","author":[{"given":"Marzia","family":"Palma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hojjat-Farsangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz","family":"Kokhaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"\u00d6sterborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Mellstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2013.03.008_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1182\/blood-2009-08-207126","article-title":"How I treat CLL up front","volume":"115","author":"Gribben","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.008_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.blre.2008.05.003","article-title":"Prognostic markers in chronic lymphocytic leukemia: a comprehensive review","volume":"23","author":"Van Bockstaele","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2013.03.008_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1139\/g89-104","article-title":"Recognition and elongation of telomeres by telomerase","volume":"31","author":"Blackburn","year":"1989","journal-title":"Genome"},{"key":"10.1016\/j.exphem.2013.03.008_bib4","first-page":"3043","article-title":"Telomerase activity in\u00a0vivo in human malignant hematopoietic cells","volume":"9","author":"Nilsson","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2013.03.008_bib5","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1073\/pnas.92.20.9082","article-title":"Telomerase activity in normal and malignant hematopoietic cells","volume":"92","author":"Broccoli","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2013.03.008_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jb\/mvq119","article-title":"Alternative lengthening of telomeres pathway: recombination-mediated telomere maintenance mechanism in human cells","volume":"149","author":"Nabetani","year":"2011","journal-title":"J Biochem"},{"key":"10.1016\/j.exphem.2013.03.008_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.yexcr.2005.05.002","article-title":"Comparison of early passage, senescent and hTERT immortalized endothelial cells","volume":"309","author":"Chang","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2013.03.008_bib8","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.exphem.2013.03.008_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.exphem.2013.03.008_bib10","first-page":"1323","article-title":"Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review","volume":"62","author":"Meeker","year":"1997","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.exphem.2013.03.008_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1365-2141.1999.01620.x","article-title":"Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage","volume":"106","author":"Trentin","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2013.03.008_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2003-04-1345","article-title":"Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations","volume":"103","author":"Damle","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.008_bib13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2008.399","article-title":"Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia","volume":"23","author":"Rossi","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.03.008_bib14","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood-2007-05-092759","article-title":"Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia","volume":"111","author":"Roos","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.008_bib15","doi-asserted-by":"crossref","unstructured":"Brugat T, Gault N, Baccelli I, et\u00a0al. Aberrant telomere structure is characteristic of resistant chronic lymphocytic leukaemia cells. Leukemia;24:246\u2013251.","DOI":"10.1038\/leu.2009.213"},{"key":"10.1016\/j.exphem.2013.03.008_bib16","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1182\/blood-2007-09-111245","article-title":"Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia","volume":"111","author":"Poncet","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.008_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-1759(00)00297-0","article-title":"Simultaneous flow cytometric analysis of cell surface markers and telomere length: analysis of human tonsilar B cells","volume":"247","author":"Batliwalla","year":"2001","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.exphem.2013.03.008_bib18","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.159.3.1068","article-title":"Telomerase is up-regulated in human germinal center B cells in\u00a0vivo and can be re-expressed in memory B cells activated in\u00a0vitro","volume":"159","author":"Hu","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2013.03.008_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1034\/j.1600-0609.2001.00588.x","article-title":"Telomerase regulation and telomere dynamics in germinal centers","volume":"67","author":"Norrback","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2013.03.008_bib20","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.94.20.10827","article-title":"Telomere lengthening and telomerase activation during human B cell differentiation","volume":"94","author":"Weng","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2013.03.008_bib21","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood-2012-02-409110","article-title":"T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients","volume":"120","author":"Damle","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.008_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0092-8674(00)80538-3","article-title":"hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization","volume":"90","author":"Meyerson","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2013.03.008_bib23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/ejso.2001.1151","article-title":"The significance of human telomerase reverse transcriptase (hTERT) in cancer","volume":"27","author":"Kirkpatrick","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.exphem.2013.03.008_bib24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.onc.1205075","article-title":"Telomeres and telomerase in hematologic neoplasia","volume":"21","author":"Ohyashiki","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2013.03.008_bib25","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.leu.2404607","article-title":"Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome","volume":"21","author":"Terrin","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.03.008_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2199-7-26","article-title":"Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): Analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues","volume":"7","author":"Saeboe-Larssen","year":"2006","journal-title":"BMC Mol Biol"},{"key":"10.1016\/j.exphem.2013.03.008_bib27","first-page":"4168","article-title":"Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts","volume":"58","author":"Ulaner","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2013.03.008_bib28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1103>3.0.CO;2-V","article-title":"Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development","volume":"91","author":"Ulaner","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2013.03.008_bib29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<330::AID-IJC6>3.0.CO;2-U","article-title":"Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium","volume":"85","author":"Ulaner","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2013.03.008_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.neo.7900112","article-title":"The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity","volume":"2","author":"Colgin","year":"2000","journal-title":"Neoplasia"},{"key":"10.1016\/j.exphem.2013.03.008_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.neo.7900113","article-title":"An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity","volume":"2","author":"Yi","year":"2000","journal-title":"Neoplasia"},{"key":"10.1016\/j.exphem.2013.03.008_bib32","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/annonc\/mdh389","article-title":"hTERT expression and prognosis in B-chronic lymphocytic leukemia","volume":"15","author":"Tchirkov","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.exphem.2013.03.008_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0959-437X(01)00268-4","article-title":"Telomerase regulation: not just flipping the switch","volume":"12","author":"Aisner","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.exphem.2013.03.008_bib34","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1158\/1078-0432.CCR-05-0099","article-title":"Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues","volume":"11","author":"Fan","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2013.03.008_bib35","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.onc.1205163","article-title":"Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?","volume":"21","author":"Kyo","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2013.03.008_bib36","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ceb.2006.03.003","article-title":"Telomerase regulation and stem cell behaviour","volume":"18","author":"Flores","year":"2006","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.exphem.2013.03.008_bib37","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.008_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.exphem.2013.03.008_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.exphem.2006.10.006","article-title":"Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells","volume":"35","author":"Kokhaei","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2013.03.008_bib40","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1093\/nar\/gkn1027","article-title":"Telomere length measurement by a novel monochrome multiplex quantitative PCR method","volume":"37","author":"Cawthon","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2013.03.008_bib41","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1182\/blood-2004-11-4394","article-title":"Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status","volume":"105","author":"Grabowski","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.008_bib42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.bjc.6600763","article-title":"Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications","volume":"88","author":"Hultdin","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.exphem.2013.03.008_bib43","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1093\/nar\/29.23.4818","article-title":"Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells","volume":"29","author":"Yi","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2013.03.008_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.1178","article-title":"Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity","volume":"198","author":"Zaffaroni","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.exphem.2013.03.008_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1373\/clinchem.2006.073015","article-title":"Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer","volume":"53","author":"Mavrogiannou","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.exphem.2013.03.008_bib46","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1593\/neo.08644","article-title":"Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant","volume":"10","author":"Lincz","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.exphem.2013.03.008_bib47","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1089\/thy.2008.0101","article-title":"Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms","volume":"18","author":"Wang","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.exphem.2013.03.008_bib48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.clinbiochem.2004.05.015","article-title":"Splice variants as cancer biomarkers","volume":"37","author":"Brinkman","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.exphem.2013.03.008_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/gcc.20156","article-title":"Alterations of pre-mRNA splicing in cancer","volume":"42","author":"Kalnina","year":"2005","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X13001203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X13001203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T19:06:49Z","timestamp":1688152009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X13001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0301472X13001203"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2013.03.008","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}